ClassID:

95260

C07D405/12 - page 11 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#3001
20170152230
2017-06-01

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#3002
20170152226
2017-06-01

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

#3003
20170145038
2017-05-25

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#3004
20170145027
2017-05-25

Antiviral compounds

#3005
20170144997
2017-05-25

Modulators of chemokine receptors

#3006
20170144996
2017-05-25

Inhibitors of CXCR2

#3007
20170144995
2017-05-25

Amide compound

#3008
20170144978
2017-05-25

Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections

#3009
20170144971
2017-05-25

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#3010
20170143672
2017-05-25

Tetrazole-substituted arylamides as PXand PXantagonists

#3011
20170143665
2017-05-25

Synthesis and use of amine-containing flavonoids as potent anti-leishmanial agents

#3012
20170141311
2017-05-18

Compound for organic electronic element, organic electronic element using same, and electronic device comprising same

#3013
20170137416
2017-05-18

6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives

#3014
20170137405
2017-05-18

Compounds for the treatment of HIV

#3015
20170133602
2017-05-11

Heterocyclic compound and organic light emitting element using same

#3016
20170129877
2017-05-11

Cyclic amine azaheterocyclic carboxamides

#3017
20170129861
2017-05-11

6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides

#3018
20170129855
2017-05-11

Tetrahydronaphthalene estrogen receptor modulators and uses thereof

#3019
20170121340
2017-05-04

Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C

#3020
20170121314
2017-05-04

Heteroaryl substituted heterocyclyl sulfones

#3021
20170121308
2017-05-04

Nitrogen-containing heterocyclic compound

#3022
20170121302
2017-05-04

Cyclopropylamines as LSD1 inhibitors

#3023
20170121300
2017-05-04

Method of fluorination using iodonium ylides

#3024
20170121299
2017-05-04

Anticancer agent

#3025
20170121292
2017-05-04

HIV REPLICATION INHIBITING PYRIMIDINES

#3026
20170121291
2017-05-04

COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY

#3027
20170120231
2017-05-04

Complexes

#3028
20170119780
2017-05-04

Aryl- or heteroaryl-substituted benzene compounds

#3029
20170117482
2017-04-27

Compound and organic light-emitting device including the same

#3030
20170114071
2017-04-27

TrkA kinase inhibitors, compositions and methods thereof

#3031
20170114061
2017-04-27

PRMT5 inhibitors and uses thereof

#3032
20170114055
2017-04-27

Histone demethylase inhibitors

#3033
20170114050
2017-04-27

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

#3034
20170114049
2017-04-27

2,5-DISUBSTITUTED CYCLOPENTANE CARBOXYLIC ACIDS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES

#3035
20170114048
2017-04-27

Compounds and combinations for the treatment of HIV

#3036
20170114022
2017-04-27

Benzoimidazol-1,2-yl amides as Kv7 channel activators

#3037
20170114017
2017-04-27

C5AR ANTAGONISTS

#3038
20170112816
2017-04-27

Cyclopropylamines as LSD1 inhibitors

#3039
20170107226
2017-04-20

Dihydroxy aromatic heterocyclic compound

#3040
20170107225
2017-04-20

Heteroaryl derivatives as CFTR modulators

#3041
20170107207
2017-04-20

AMINOPYRAZOLONE DERIVATIVE

#3042
20170107206
2017-04-20

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#3043
20170107205
2017-04-20

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#3044
20170107202
2017-04-20

Compounds useful as immunomodulators

#3045
20170107194
2017-04-20

Therapeutically active compounds and their methods of use

#3046
20170107178
2017-04-20

Indole derivatives for use in medicine

#3047
20170101400
2017-04-13

Trail enhancers for the selective killing of cancer cells

#3048
20170096414
2017-04-06

Alkylation of picolinamides with substituted chloroacylals utilizing a crown ether catalyst

#3049
20170096413
2017-04-06

Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors

#3050
20170096405
2017-04-06

Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same

#3051
20170096404
2017-04-06

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#3052
20170096403
2017-04-06

PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF

#3053
20170096399
2017-04-06

Pyrazole compounds and their use as T-type calcium channel blockers

#3054
20170096392
2017-04-06

Aromatic heterocyclic derivatives and pharmaceutical applications thereof

#3055
20170092873
2017-03-30

COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

#3056
20170088552
2017-03-30

Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists

#3057
20170088531
2017-03-30

Benzo-fused heterocyclic derivatives useful as agonists of GPR120

#3058
20170088520
2017-03-30

DEUBIQUITINASE INHIBITORS

#3059
20170088519
2017-03-30

Amine derivatives as potassium channel blockers

#3060
20170081315
2017-03-23

Phenyl and benzodioxinyl substituted indazoles derivatives

#3061
20170081314
2017-03-23

Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto

#3062
20170081290
2017-03-23

2,4-pyrimidinediamine compounds and their uses

#3063
20170081287
2017-03-23

Antidiabetic tricyclic compounds

#3064
20170079967
2017-03-23

Positive allosteric modulators of nicotinic acetylcholine receptor

#3065
20170077411
2017-03-16

Compound and organic light-emitting device including same

#3066
20170073335
2017-03-16

1,3-benzodioxole derivative

#3067
20170073325
2017-03-16

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#3068
20170073314
2017-03-16

Human plasma kallikrein inhibitors

#3069
20170073313
2017-03-16

Benzomorphan analogs and use thereof

#3070
20170073286
2017-03-16

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#3071
20170071919
2017-03-16

Pyridine and pyrazine derivative for the treatment of CF

#3072
20170066782
2017-03-09

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

#3073
20170066749
2017-03-09

Fumagillol heterocyclic compounds and methods of making and using same

#3074
20170066747
2017-03-09

Mcl-1 antagonists

#3075
20170066741
2017-03-09

2-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's Disease

#3076
20170066725
2017-03-09

N-(pyrid-4-yl)amides and N-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use

#3077
20170066718
2017-03-09

Urea derivative or pharmacologically acceptable salt thereof

#3078
20170066717
2017-03-09

NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS

#3079
20170065582
2017-03-09

Combinations for the treatment of neuroblastoma

#3080
20170065574
2017-03-09

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#3081
20170062728
2017-03-02

Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof

#3082
20170062720
2017-03-02

Condensed-cyclic compound and organic light emitting device comprising the same

#3083
20170057982
2017-03-02

Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereof

#3084
20170057939
2017-03-02

Carboxylic acid derivatives and use thereof in the preparation of prodrugs

#3085
20170057928
2017-03-02

Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

#3086
20170057926
2017-03-02

Arginine methyltransferase inhibitors and uses thereof

#3087
20170057919
2017-03-02

Process for the preparation of histamine H3 receptor modulators

#3088
20170056382
2017-03-02

Compounds and methods for kinase modulation, and indications therefor

#3089
20170055528
2017-03-02

Macrocyclic picolinamides as fungicides

#3090
20170050974
2017-02-23

Heterocyclic compound

#3091
20170050956
2017-02-23

Piperazine derivatives for treating disorders

#3092
20170050954
2017-02-23

Diaminotriazine compounds as herbicides

#3093
20170050939
2017-02-23

SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES

#3094
20170050937
2017-02-23

COMPOUNDS AND THERAPEUTICAL USE THEREOF

#3095
20170050936
2017-02-23

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#3096
20170050931
2017-02-23

Inhibitors of RPN11

#3097
20170050925
2017-02-23

Sulfur derivatives as chemokine receptor modulators

#3098
20170049907
2017-02-23

Hydrazinyl-pyrrolo compounds and methods for producing a conjugate

#3099
20170049750
2017-02-23

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3100
20170044141
2017-02-16

Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers

#3101
20170044133
2017-02-16

2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof

#3102
20170044115
2017-02-16

Disubstituted 1, 2, 4-triazine compound

#3103
20170044111
2017-02-16

Janus kinase inhibitors and uses thereof

#3104
20170044104
2017-02-16

NEW PESTICIDAL COMPOUNDS AND USES

#3105
20170037044
2017-02-09

Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereof

#3106
20170037040
2017-02-09

Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

#3107
20170037036
2017-02-09

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor I

#3108
20170037010
2017-02-09

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

#3109
20170037009
2017-02-09

Pyridone amides as modulators of sodium channels

#3110
20170035775
2017-02-09

Quinoxaline derivatives as GPR6 modulators

#3111
20170035751
2017-02-09

AZA spiro alkane derivatives as inhibitors of metalloproteases

#3112
20170029425
2017-02-02

Diazaspirocycloalkane and azaspirocycloalkane

#3113
20170029390
2017-02-02

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

#3114
20170029378
2017-02-02

Kinase inhibitor

#3115
20170029372
2017-02-02

Binding function (BF) site compounds as therapeutics and methods for their use

#3116
20170027935
2017-02-02

PRMT5 inhibitors and uses thereof

#3117
20170027173
2017-02-02

INSECTICIDAL COMPOUNDS

#3118
20170022219
2017-01-26

Neprilysin inhibitors

#3119
20170022195
2017-01-26

Aryl and heteroaryl ether compounds as ROR gamma modulators

#3120
20170022191
2017-01-26

Benzamides

#3121
20170022186
2017-01-26

Halogenated quinazolin-THF-amines as PDE1 inhibitors

#3122
20170022164
2017-01-26

Quinolone-3-diarylethers

#3123
20170022157
2017-01-26

Salts and prodrugs of 1-methyl-D-tryptophan

#3124
20170020904
2017-01-26

Neprilysin inhibitors

#3125
20170020886
2017-01-26

Amido-substituted azole compounds

#3126
20170020840
2017-01-26

Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors

#3127
20170015675
2017-01-19

Substituted tricyclics and method of use

#3128
20170015645
2017-01-19

SUBSTITUTED PYRAN DERIVATIVES

#3129
20170015633
2017-01-19

Pyrimidone carboxamide compounds as PDE2 inhibitors

#3130
20170015631
2017-01-19

PKM2 modulators and methods for their use

#3131
20170014523
2017-01-19

Spliceostatin analogs and methods for their preparation

#3132
20170014381
2017-01-19

Somatostatin receptor subtype 4 (SSTR4) agonists

#3133
20170012205
2017-01-12

Compound and organic light-emitting device including the same

#3134
20170008884
2017-01-12

Cysteine protease inhibitors and uses thereof

#3135
20170008880
2017-01-12

Neprilysin inhibitors

#3136
20170008844
2017-01-12

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#3137
20170007610
2017-01-12

NOVEL HETEROBICYCLIC COMPOUNDS AS KAPPA OPIOID AGONISTS

#3138
20170007601
2017-01-12

Pyrimidine FGFR4 inhibitors

#3139
20170002040
2017-01-05

Therapeutics for the treatment of glaucoma

#3140
20170001968
2017-01-05

Aminotriazole-based KDM1A inhibitors as epigenetic modulators

#3141
20160376294
2016-12-29

Compounds useful in the synthesis of halichondrin B analogs

#3142
20160376260
2016-12-29

Slow release of organoboronic acids in cross-coupling reactions

#3143
20160376240
2016-12-29

6 Phenyl or 6 Pyridin 3 YL Indazole Derivatives and Methods of Use

#3144
20160376238
2016-12-29

Therapeutic compounds

#3145
20160376232
2016-12-29

Kinase inhibitors

#3146
20160374990
2016-12-29

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto

#3147
20160372666
2016-12-22

Compound, organic optoelectronic element comprising same and display device thereof

#3148
20160368946
2016-12-22

Tripeptide epoxy ketone protease inhibitors

#3149
20160368930
2016-12-22

Compositions and methods for treating cancer

#3150
20160368914
2016-12-22

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

#3151
20160368907
2016-12-22

PRMT5 inhibitors and uses thereof

#3152
20160368904
2016-12-22

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

#3153
20160368900
2016-12-22

Plant growth regulating compounds

#3154
20160368881
2016-12-22

Therapeutic compounds

#3155
20160368874
2016-12-22

1,4-substituted piperidine derivatives

#3156
20160367564
2016-12-22

Pharmaceutical compound

#3157
20160367526
2016-12-22

Azetidine estrogen receptor modulators and uses thereof

#3158
20160366885
2016-12-22

Fungicide N-cycloalkyl-N-bicyclicmethylene-carboxamide derivatives

#3159
20160362535
2016-12-15

5H-furan-2-one derivatives stabilization of organic material

#3160
20160362439
2016-12-15

Cyclic peroxides as prodrugs for selective delivery of agents

#3161
20160362427
2016-12-15

Bridged bicyclic kallikrein inhibitors

#3162
20160362421
2016-12-15

Fused heterocyclic compounds as ion channel modulators

#3163
20160362404
2016-12-15

Pyrimidine compounds containing seven-membered fused ring systems

#3164
20160362398
2016-12-15

Amide compounds for treatment of complement mediated disorders

#3165
20160362396
2016-12-15

Quinazolines as potassium ion channel inhibitors

#3166
20160362388
2016-12-15

CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION

#3167
20160362378
2016-12-15

MCT4 inhibitors for treating disease

#3168
20160362375
2016-12-15

Iodine(II)-mediated radiofluorination

#3169
20160362373
2016-12-15

Pro-neurogenic compounds

#3170
20160362372
2016-12-15

PRO-NEUROGENIC COMPOUNDS

#3171
20160362370
2016-12-15

Nuclear receptor modulators

#3172
20160361329
2016-12-15

COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#3173
20160361287
2016-12-15

Compositions and methods for inhibiting cytochrome P450

#3174
20160355521
2016-12-08

Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain

#3175
20160355511
2016-12-08

NOVEL 1-SUBSTITUTED INDAZOLE DERIVATIVE

#3176
20160355488
2016-12-08

Triazoles for the treatment of Demyelinating Diseases

#3177
20160355487
2016-12-08

Substituted phenazines as antimicrobial agents

#3178
20160355483
2016-12-08

COMPOUND BINDING TO PPARG BUT NOT ACTING AS PROMOTER AND PHARMACEUTICAL COMPOSITION FOR TREATING PPARG-RELATED DISEASES CONTAINING SAME AS ACTIVE INGREDIENT

#3179
20160355480
2016-12-08

Substituted pyridines and method of use

#3180
20160355479
2016-12-08

Sulfonamide compounds and uses as TNAP inhibitors

#3181
20160355474
2016-12-08

3,3′-disubstituted indolines as inhibitors of cholesterol ester transfer protein

#3182
20160354374
2016-12-08

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

#3183
20160347768
2016-12-01

Compounds for use as GPR120 agonists

#3184
20160347761
2016-12-01

Inhibitors of histone deacetylase

#3185
20160347760
2016-12-01

Bicyclic-fused heteroaryl or aryl compounds

#3186
20160347742
2016-12-01

Heterocyclic estrogen receptor modulators and uses thereof

#3187
20160347714
2016-12-01

Histone demethylase inhibitors

#3188
20160347708
2016-12-01

Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides

#3189
20160346402
2016-12-01

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

#3190
20160340445
2016-11-24

Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease

#3191
20160340346
2016-11-24

Itraconazole analogues and methods of use thereof

#3192
20160340341
2016-11-24

Substituted benzooxadiazole DNA-PK inhibitors

#3193
20160340319
2016-11-24

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

#3194
20160340315
2016-11-24

Factor XIa inhibitors

#3195
20160340308
2016-11-24

TETRACYCLIC COMPOUND

#3196
20160339000
2016-11-24

Triazolone compounds as mPGES-1 inhibitors

#3197
20160338988
2016-11-24

TOFA analogs useful in treating dermatological disorders or conditions

#3198
20160333021
2016-11-17

Metallo-beta-lactamase inhibitors

#3199
20160333009
2016-11-17

Benzimidazole and imadazopyridine carboximidamide compounds

#3200
20160333000
2016-11-17

Pyrimidinyloxy benzene derivatives as herbicides

#3201
20160332999
2016-11-17

Heterocyclic sulfonamide derivative and medicine comprising same

#3202
20160332997
2016-11-17

Modulators of ATP-binding cassette transporters

#3203
20160332996
2016-11-17

Hepatitis B antiviral agents

#3204
20160332982
2016-11-17

Prodrugs of urolithins and uses thereof

#3205
20160332970
2016-11-17

Histone demethylase inhibitors

#3206
20160332969
2016-11-17

SUBSTITUTED BENZENE COMPOUNDS

#3207
20160331749
2016-11-17

Bromodomain inhibitors

#3208
20160326144
2016-11-10

Flouro-naphthyl derivatives

#3209
20160326143
2016-11-10

Compounds and uses

#3210
20160326108
2016-11-10

PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS

#3211
20160318958
2016-11-03

Urea derivatives useful as kinase inhibitors

#3212
20160318919
2016-11-03

Oxime-substituted amide compound and pest control agent

#3213
20160318917
2016-11-03

Nrf2 regulators

#3214
20160318916
2016-11-03

Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same

#3215
20160318910
2016-11-03

Quinazolin-THF-amines as PDE1 inhibitors

#3216
20160318892
2016-11-03

PRODRUG COMPOUNDS

#3217
20160318891
2016-11-03

TONABERSAT PRODRUGS

#3218
20160318878
2016-11-03

Methods to treat lymphoplasmacytic lymphoma

#3219
20160318870
2016-11-03

RORγ modulators

#3220
20160318864
2016-11-03

4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

#3221
20160318857
2016-11-03

N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation

#3222
20160318852
2016-11-03

Benzamides and nicotinamides as Syk modulators

#3223
20160317537
2016-11-03

Compounds

#3224
20160317532
2016-11-03

Compounds useful as modulators of TRPM8

#3225
20160317494
2016-11-03

Composition comprising tetracyclic compound

#3226
20160311805
2016-10-27

ANTI-ESTROGENIC COMPOUNDS

#3227
20160311791
2016-10-27

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTOGONISTS FOR THE TREATMENT OF OSTEOPOSOSIS

#3228
20160311784
2016-10-27

Cyclic triazo and diazo sodium channel blockers

#3229
20160311782
2016-10-27

N-arylmethyl sulfonamide negative modulators of NR2A

#3230
20160311776
2016-10-27

Substituted indazole derivatives active as kinase inhibitiors

#3231
20160311774
2016-10-27

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

#3232
20160311772
2016-10-27

Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising same

#3233
20160310465
2016-10-27

Substituted indazole derivatives active as kinase inhibitiors

#3234
20160304555
2016-10-20

PSMA imaging agents

#3235
20160304533
2016-10-20

Compounds, compositions and methods for inhibiting CNKSR1

#3236
20160304500
2016-10-20

Methods of promoting wound healing using CRM1 inhibitors

#3237
20160304466
2016-10-20

NOVEL COMPOUNDS AS JNK KINASE INHIBITORS

#3238
20160304463
2016-10-20

3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#3239
20160304451
2016-10-20

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#3240
20160303128
2016-10-20

Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors

#3241
20160303123
2016-10-20

Chromene derivatives as phoshoinositide 3-kinases inhibitors

#3242
20160303087
2016-10-20

Estrogen receptor beta agonists for use in treating mesothelioma

#3243
20160302414
2016-10-20

INSECTICIDAL COMPOUNDS

#3244
20160297823
2016-10-13

Substituted amino triazoles, and methods using same

#3245
20160297810
2016-10-13

Viral replication inhibitors

#3246
20160297806
2016-10-13

Inhibitors of lysine methyl transferase

#3247
20160297805
2016-10-13

Inhibitors of lysine methyl transferase

#3248
20160297797
2016-10-13

Dihydropyrazole GPR40 modulators

#3249
20160297789
2016-10-13

Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases

#3250
20160297784
2016-10-13

Taxanes compounds, preparation method therefor, and uses thereof

#3251
20160297775
2016-10-13

Quinazoline derivatives as TAM family kinase inhibitors

#3252
20160297774
2016-10-13

Substituted quinazoline compounds and methods of use thereof

#3253
20160297754
2016-10-13

N-substituted benzamides and methods of use thereof

#3254
20160297751
2016-10-13

Bis-amide derivative and use thereof

#3255
20160296525
2016-10-13

Aminoquinazoline and pyridopyrimidine derivatives

#3256
20160289218
2016-10-06

Aziridinated triglycerides and polymers formed therefrom

#3257
20160289217
2016-10-06

Coumarin based Hsp90 inhibitors with urea and ether substituents

#3258
20160289216
2016-10-06

Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1

#3259
20160289199
2016-10-06

TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion

#3260
20160289196
2016-10-06

Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same

#3261
20160289191
2016-10-06

ORGANIC COMPOUNDS

#3262
20160289186
2016-10-06

FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES III

#3263
20160289184
2016-10-06

Selective FKBP51 ligands for treatment of psychiatric disorders

#3264
20160289171
2016-10-06

IDO inhibitors

#3265
20160280693
2016-09-29

Activators of class I histone deacetlyases (HDACs) and uses thereof

#3266
20160280692
2016-09-29

N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

#3267
20160280676
2016-09-29

Sulfated and unsulfated flavonoid oligomers as cancer therapeutics

#3268
20160280667
2016-09-29

P2X4 receptor antagonist

#3269
20160280664
2016-09-29

Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents

#3270
20160280657
2016-09-29

Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain

#3271
20160280656
2016-09-29

6-aminoisoquinoline compounds

#3272
20160280649
2016-09-29

Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

#3273
20160280643
2016-09-29

N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

#3274
20160279125
2016-09-29

Treatment of diseases through administration of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

#3275
20160279096
2016-09-29

Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus

#3276
20160272653
2016-09-22

Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses

#3277
20160272625
2016-09-22

HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#3278
20160272623
2016-09-22

Formation of macromolecules using iterative growth and related compounds

#3279
20160272604
2016-09-22

3-furyl-2-cyano-2-acrylamide derivative, preparation method therefor, pharmaceutical composition and use thereof

#3280
20160272603
2016-09-22

Trail enhancers for the selective killing of cancer cells

#3281
20160272600
2016-09-22

Inhibitors of beta-secretase

#3282
20160272595
2016-09-22

Quinazolinone and isoquinolinone derivative

#3283
20160272592
2016-09-22

N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

#3284
20160272589
2016-09-22

DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE

#3285
20160272587
2016-09-22

Compounds for cognitive enhancement and methods of use thereof

#3286
20160271278
2016-09-22

Tau imaging probe

#3287
20160271105
2016-09-22

Modulators of ATP-binding cassette transporters

#3288
20160264557
2016-09-15

Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities

#3289
20160264522
2016-09-15

Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#3290
20160264518
2016-09-15

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#3291
20160263093
2016-09-15

S1P modulating agents

#3292
20160263083
2016-09-15

Antibacterial agents: aryl myxopyronin derivatives

#3293
20160257672
2016-09-08

FUNCTIONALIZED FURAN-2-SULFONAMIDES EXHIBITING ENDOTHELIAL LIPASE INHIBITION

#3294
20160257671
2016-09-08

SHIP1 modulators and methods related thereto

#3295
20160257655
2016-09-08

Synthesis of novel inhibitors of isoprenoid biosynthesis (ISPF)

#3296
20160257650
2016-09-08

MONOARYLATION OF AROMATIC AMINES

#3297
20160257645
2016-09-08

Inhibitors of human immunodeficiency virus replication

#3298
20160251372
2016-09-01

Sweet flavor modifier

#3299
20160251358
2016-09-01

Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors

#3300
20160251351
2016-09-01

Inhibitors of histone deacetylase